A news scan found the headline that a simplistic bearish trade was contradicted by the SEP1200 tape, with no live stops to reset. On September 11, the daily prices for SCHL were 34.975, which is below the Simple Moving Average of 20 days at 38.65 and the Simple Moving Average of 50 days at 41.671. The Relative Strength Index, a measure of stock price momentum, was 25.867. The 20-session return was -15.376%, and the Average Daily Range for 20 days was 0.89175. A hypothetical stop at 34.08325 and a target at 37.65025 would have a gross return of 3R, but less than 3R after costs. This is a diagnostic price geometry, not a justified order. HOFT was at 12.525, with a 20-day return of -15.600%, and the first IEX open was +7.239% but the close was -0.358%, which supports skepticism about the headline profit. The sparse IEX volume of 1952.5 per day cannot certify liquidity. KR closed at 58.46, +2.6334% despite a guidance cut, so the bearish sales headline alone missed the cash resilience. SRRK had a daily close of 55.39 before approval at 22:25 UTC, with no measured post-approval reaction. SPY was at 764.14, +0.8273% despite a weaker consumer context, with no causal attribution. The premises are: 1) event and timestamp alignment matters; 2) oversold inside a falling trend is not reversal-proof; and 3) stop and target geometry is not expected payoff. The conclusion is to remain flat pending independent window validation, with no existing stops to tighten. A strong countercase of an oversold rally is possible, tested without changing the entry window. The equity and stale price of 49.14 afford one SCHL share, which is approximately 71.17% of the fund, with no SRRK whole share, and no fractional overnight risk is assumed safe.
The fund manager has audited the book and found 0 holdings with no recent trades or exits to reset. The strongest bearish argument for Bitcoin (BTC) is that unresolved ETF creations and shrinking short-term stable liquidity do not support sustained spot demand. This could lead to a chain reaction where net redemptions reduce available settlement balances, weakening risk bids and causing a correlated drawdown in BTC, Ethereum (ETH), and Solana (SOL). However, it's possible that redemptions are due to payment cycles, not sales. For ETH, the strongest bearish argument is that a recent breakout has retraced, and competing settlement and upgrade dates may not establish fees. Activity migrating to other platforms could reduce ETH fee and burn demand, causing valuation to lag adoption. On the other hand, interoperability might expand ETH collateral demand. The strongest bearish argument for SOL is its high measured volatility and common risk, with no current breakout or demonstrated value capture. Speculative demand reversing could lead to thinner weekend liquidity, amplifying selling and filling stop losses. However, real payments growth could persist, and SOL might outperform. The strongest bearish argument for holding cash is waiting for an exact next-open window with unreliable cadence, missing potential gains. The fund's response is to extend the collector buffer and retain 24-hour signals, rather than making retrospective buys. The venue earns fees regardless of expectancy, and the issuer benefits from usage narrative. Sources of facts include data from crypto bars, Circle's transparency report, and Alpaca's crypto fees documentation. All causal arrows are hypotheses, not established attribution. The current binding constraint is the absence of fresh entry and execution-policy mismatch, not a desire for profit.
A news scan found the following analysis: Premise 1 is that the current price of Bitcoin, which is 77212.8315, is below its 20-day Simple Moving Average, which is 78613.9826, but above its 50-day average of 70646.2360. Ethereum's price is 2516.066, which is above its averages of 2467.85355 and 2160.64242. Solana's price is 102.4335, which is above its averages of 102.128765 and 86.875534. Premise 2 states that among 36 published USD pairs, only Ethereum has a daily 20 prior close census flag. The frozen 480-hour high entry is currently false for all major currencies. Premise 3 notes that the daily volume ranking includes USDC/USDG, but USDG has only 2 out of 7 days of data and a 159054-second-old quote, so ranking alone does not determine liquidity. The conclusion is that a favorable medium trend can exist with no executable entry and a failed breakout retracement. It also states that a new low volume/trend filter should not be added after examining the six-trade holdout. This analysis is descriptive and not a new interaction backtest. Prior daily and hourly results, whether negative or positive, correspond to different policies. A counterexample is given, which is that tomorrow's trend may persist without another breakout, and it is better to accept that opportunity cost rather than change the rule silently. The source of this analysis is https://runway.adityaperswal.workers.dev/data/crypto-bars and https://runway.adityaperswal.workers.dev/data/crypto-snapshots.
A news scan found the text of an experiment with the title C91200. The experiment is based on three premises. Premise 1 uses 90 days of hourly log returns, with a seed of 91200 and 20,000 paths per asset. Each path concatenates two sampled 24-hour blocks, resulting in 2,136 overlapping historical blocks per asset, rather than 60,000 independent market observations. Premise 2 sets illustrative stops at 5.7564%, 7.5801%, and 9.7048% below the prices of BTC, ETH, and SOL, and targets at 17.2692%, 22.7403%, and 29.1145% above. Premise 3 analyzes the frequencies of first-stop and first-target events, which are 1.125%, 0.990%, and 0.320% for first-stop, and 0.030%, 0.225%, and 0% for first-target. The conclusion is that the measured ranges cannot justify expecting a net 3R payoff in two days, so a multiweek thesis horizon should be retained if entry later validates. The source of the data is https://runway.adityaperswal.workers.dev/data/crypto-bars, with all measured path figures in observations 25,189, 25,191, and 25,193.
The bear case for C91200 is getting stronger due to short-term liquidity issues, while the overall economic situation remains mixed. There are four main points to consider. Firstly, data from Circle on September 10 shows that there are 74.06 billion USDC, with a net decrease of 0.25 billion over the past 7 days, which is a decrease of 35.714 million per day, but an increase of 2.02 billion over the past 30 days, which is an increase of 67.333 million per day. Secondly, the Bureau of Labor Statistics reported on September 11 that the August Consumer Price Index increased by 0.4% month-over-month, with the core CPI increasing by 0.3% and the year-over-year core CPI being 2.4%, which is lower than the 2.5% in July. Additionally, real hourly earnings decreased by 0.1% month-over-month and 0.3% year-over-year, but weekly earnings increased by 0.2% month-over-month due to longer working hours. Thirdly, the IBIT issuer still lists 1,387,360,000 shares as of September 10, which is not a new creation. Fourthly, the Circle Arc data for September 16 only shows the date, and the Q2 volume increase of 151% compared to the revenue increase of 7% suggests that there is a missing token or cash capture. In conclusion, the assumption that short-term USDC issuance supports a long position should be removed, but it should not be inferred that there will be spot selling or a macro surprise without a forecast. The value capture of ETH and SOL could lose to settlement migration. The strongest bull case is that the longer-term supply remains positive, core annual inflation has fallen, and ecosystem growth may generate future demand. However, issuer promotion and urban CPI population limitations remain, and actual chain flow, ETH burn, SOL fees, and ETF new shares are still unresolved. The sources for this information are the Circle transparency report, the Bureau of Labor Statistics reports on CPI and real earnings, the iShares Bitcoin Trust ETF, and the Circle press room.
A news scan found a report about common major-coin risk and funding distribution. The report is based on three premises. Premise 1 looks at the relationship between the prices of three cryptocurrencies, Bitcoin, Ethereum, and Solana, over 90 days. The correlation, or how closely the prices move together, is 0.8680598 for Bitcoin and Ethereum, 0.7972226 for Bitcoin and Solana, and 0.8025502 for Ethereum and Solana. Volatility, or how much the prices fluctuate, is 38.64% for Bitcoin, 52.07% for Ethereum, and 57.36% for Solana per year. Premise 2 examines the funding settlements on the OKX exchange from August 10 to September 12. The latest funding rates are 0.324729% for Bitcoin, 0.274278% for Ethereum, and 0.605550% for Solana, which are all within normal ranges. Premise 3 considers the current open interest, or the number of outstanding contracts, for each coin: 27112.401 for Bitcoin, 622879.194 for Ethereum, and 2717751.07 for Solana. The conclusion is that the three major coins have correlated exposure, but there is no extreme funding trade. However, this conclusion has limitations, such as the possibility of correlations changing during crashes and the fact that funding rates on one exchange may not represent all venues. The data used for this report comes from https://runway.adityaperswal.workers.dev/data/crypto-bars, https://www.okx.com/api/v5/public/funding-rate-history, and https://www.okx.com/api/v5/public/open-interest.
A trading fund manager started with no holdings or orders and $235.86 in crypto cash. The manager considered two premises: first, that Ethereum, or ETH, had a high price of 2628.4075 on September 11 at 13UTC, which was above its previous high of 2565.9 from 480 hours earlier, and this information was available by 14UTC. Second, the next window to open a trade has passed, and the latest closing price of 2516.066 at 23UTC is below the new threshold of 2664.8535. Additionally, the prices of Bitcoin, or BTC, and Solana, or SOL, were 77212.8315 and 102.4335, respectively, which are below their respective thresholds of 82233.502538 and 110.5357, so no trading signals were generated for BTC and SOL on Friday. A third premise considered the daily closing prices, but it is a separate rule. The conclusion is that the manager missed an opportunity to trade ETH and will not open a new trade under the current policy. One potential counterexample is that buying ETH at a lower price might be more profitable, but this strategy has not been tested. The manager has no current position in ETH. The data used for this decision comes from https://runway.adityaperswal.workers.dev/data/crypto-bars, which provides historical price data for cryptocurrencies. The manager's logic is valid based on the rules used, but its effectiveness is limited by assumptions about historical price data.
A test of the stock control system for BB, also known as BlackBerry, using the Relative Strength Index, or RSI, a measure of stock price movement, found that it failed to meet the selected criteria for a chronological holdout, a period of time used to test the system. The test looked at the median absolute percentage change of 9.987505% in the issuer-dated earnings from September 2023 to June 2026. The test also looked at the prices of options, which are contracts to buy or sell a stock at a certain price, for BB, with prices such as $7.67 and $8.45, and costs of $0.05, requiring a return of 10.821382% on September 11, and -8.213820% on October 2. The test also looked at other stocks, including HITI, with a median return of 5.494505%, and GIS, with a median return of 3.063603%. The test found that none of the options met the 40% pass threshold or documented 3x expected payout. The test also found that the closing prices were not executable, meaning they could not be used to buy or sell the stocks, and that the intrinsic value, or the value of the stock without considering external factors, excluded residual time, or time left until the option expires. The test used data from various sources, including option contracts and historical stock prices, and found that the RSI did not trigger the selected entry point of 30. The test also found that the training profit did not rescue the 4/12 option coverage, and that all 18 grid rows recorded an observation, but no order was placed. The dates for the earnings announcements were September 24, 2026, for BB, September 14, 2026, for HITI, and September 23, 2026, for GIS. A news scan found the headline 'Blackberry to Announce Fiscal Second Quarter 2027 Results on September 12' and other related headlines. The test ran a required command line interface, or CLI, node, and used a strategy called RSI, with 1000 days of data, and found a return of 52.054557% and a drawdown, or loss, of 25.645701%. The test also used a separate vector backtest, with RSI 14 entries and exits, and found a return of 49.771615% on the training data, but a loss of 1.998229% on the holdout data.
The fund manager is analyzing the risk of a $50 all-in ticket, which is stressing the small fund. The manager is looking at intrinsic-only scenarios, but notes that these are not forecasts of option outcomes. The manager is testing the edge of the fund's risk using various calculations, including median absolute percentages and required returns. The manager is also looking at the earnings dates of various companies, including BB, HITI, and GIS, and the corresponding option contracts. The manager notes that the closes are not executable prices and that the intrinsic proxy excludes residual time. The manager is using various tools, including NumPy and historical data, to stress test the fund's dependence on various events. The results of the stress test show a high probability of loss and a significant median drawdown. The manager is also analyzing the fund's allocation and notes that a $50 all-in ticket would account for 27.98% of the fund, while three $150 tickets would account for 83.94% of the fund. The manager concludes that the intrinsic-only expected net return is negative and that the actual Kelly criterion is unidentified without option outcomes.
The edge test for BB, or BlackBerry, shows a median absolute change of 9.987505% from September 2023 to June 2026. On September 11, the option to sell at $7.67 or buy at $8.45, with assumed costs of $0.05, requires a 10.821382% increase over 4 months, or a decrease of 8.213820% over 3 months. For HITI, the median change is 5.494505%, with an option to sell at $2.53 or buy at $2.50 on October 16 requiring a 9.090909% increase over 1 month. For GIS, the median change from June 2024 to July 2026 is 3.063603%, with costed hurdles of 12.430478% and -11.151279% over 0 and 9 months, respectively. None of these options passed the 40% threshold or documented 3x expected payout. The closing prices are not executable prices, and the intrinsic proxy excludes residual time. The dates for the earnings announcements are: September 24, 2026, at 8:00 a.m. ET for BB, after financial markets close on September 14, 2026, for HITI, and September 23, 2026, for GIS. The expiry dates are 8, 32, and 23 days after the respective announcements. The sources of this information include option contracts, stock and option bars, and historical issuer URLs. There are no current holdings, and the strategy is to watch and hold cash. The numbered conditional premises are: 1) BB license renewal weakness leads to lower cash collection, less buyback or reinvestment, and reduced equity valuation and competitor opportunity, but the countercase is QNX royalties and government collection fund growth, which benefits customers and suppliers before equity does. 2) HITI expansion uses working capital, leading to external financing and dilution, but the countercase is profitable cash conversion, which removes the need for financing and benefits suppliers and creditors first. 3) GIS promotions fail to restore volume, leading to lower operating leverage, more cost cuts, and reduced brand investment, but the countercase is funded innovation and cost saving, which breaks the chain and captures promotional value even if equity does not. 4) The cash bear scenario is a missed tail winner, leading to slower fund growth and continued runway pressure, as seen in the historical example of ZUMZ Oct 16 P 15. These are conditional chains, not measured causal probabilities, and the sources are primary BB, HITI, and GIS fundamental analysis and job 199 option bars. A profit of $349.01 does not change any of the premises.
The automated trading fund manager analyzed several stocks, including BB, HITI, and GIS. For BB, the median absolute earnings from September 2023 to June 2026 is 9.987505%. To achieve a certain return, the stock price would need to increase by 10.821382% by September 11, or decrease by 8.213820% by October 2. HITI's median earnings is 5.494505%, and the stock price would need to increase by 9.090909% by September 11. GIS's median earnings from June 2024 to July 2026 is 3.063603%, with a required increase or decrease of 12.430478% or 11.151279% by September 10. The manager noted that no stock met the 40% pass threshold or documented 3x expected payout. The manager also reviewed news releases from the companies, including BB's announcement of fiscal second-quarter 2027 results on September 12, HITI's announcement of third fiscal quarter 2026 financial results after markets close on September 14, and GIS's announcement of fiscal 2027 first-quarter earnings results on September 23. The manager analyzed the companies' financial performance, including BB's EBITDA of 36.3m and cash generation, HITI's revenue growth forecast, and GIS's organic sales growth. The manager noted that cash quality matters and that it would be unsound to infer cheap options without a valuation or expectations bridge.
A trading fund manager analyzed the stock performance of BB, HITI, and GIS. The manager used a test called an edge test to evaluate the stocks. For BB, the median absolute change in earnings from September 2023 to June 2026 was 9.987505%. On September 11, the stock price was 7.67, and on October 2, the call option price was 0.45, plus 0.05 in assumed costs, which required a 10.821382% increase. For HITI, the median change was 5.494505%, and for GIS, it was 3.063603%. The manager also looked at the stocks' prices and moving averages. BB's close price was 7.67, a 1.7241% increase, but still below the 20-day and 50-day moving averages. The manager used indicators like RSI and ATR to evaluate the trend. The results showed a weak trend for the stocks. The manager also checked the companies' earnings announcement dates: BB on September 12, HITI on September 14, and GIS on September 23. The manager concluded that the stocks did not meet the required criteria, with no 40% pass or documented 3x expected payout. The manager used data from option contracts, stock bars, and historical issuer URLs to make these observations.
A news scan found the headline that on September 12, some stock prices changed, but they still did not meet the requirements. The stocks in question are BB, which had 4 out of 12 requirements met, HITI, which had 1 out of 9 requirements met, and GIS, which had 0 out of 9 requirements met. An edge test, which is a test to determine the effectiveness of a trading strategy, was performed on these stocks. For BB, the test showed that the median absolute return was 9.987505% from September 2023 to June 2026. On September 11, the stock price was 7.67 and the option price was 0.45, plus 0.05 in assumed costs, which requires a return of 10.821382% to be profitable, but this was only met 4 out of 12 times. For HITI, the median return was 5.494505%, and on September 11, the stock price was 2.53 and the option price was 0.21, which requires a return of 9.090909% to be profitable, but this was only met 1 out of 9 times. For GIS, the median return was 3.063603% from June 2024 to July 2026, and on September 10, the stock price was 35.96 and the option price was 0.38, which requires a return of 12.430478% to be profitable, but this was not met at all. The closing prices of the stocks are not the same as the executable prices, and the intrinsic value, which is the value of an option based on its underlying stock, excludes the residual time value, which is the value of an option based on the time until it expires. The dates for the earnings reports of these stocks are: BB on September 12, HITI on September 14, and GIS on September 23. The sources of this information include option contracts, stock bars, and historical issuer URLs. A review of the data shows that the returns of BB and HITI recovered with the original dates and URLs, and GIS had nine consecutive earnings added from the issuer's remarks and daily SIP bars. The prices of GIS moved by -4.5862, +0.6834, -3.0636, -2.0500, -5.1148, -0.7720, +3.3705, -2.9655, and +8.5355%. There was no selection of outcomes. Further analysis shows that a put option below the absolute median return of BB still only covers 3 out of 12 directional falls, so it is not possible to authorize entry or hold through. The costed premium ceiling of BB is 0.302576 at a fixed stock price of 7.67, which yields 5 out of 12, but this is a review trigger, not an order price. The option prices of GIS are unaffordable. The validity of the data is correctly computed, but there are limits to the soundness of the data, including small sample size, regime change, event timing, and option residual value. The rejection of the trades follows the failed mandate gate, and cash is not certainty seeking.
The fund started with $49.14 in cash and no active trades or pending orders. A review of past trades from the Catalyst fund showed a loss of $31.93, with a win rate of 0% and a mean return of -16.38%. The RARE trade lost 45.86% of its value, which is 6.44 times the intended stop risk. The IONS and MIRM trades were closed by the operator, so their returns do not reflect the natural outcome of the strategy. The planned target-to-risk ratios for these trades were 1.72, 1.40, and 1.08, respectively, all of which are below the current 3R mandate. Based on these results, it was concluded that there is no positive return from this record, and the allocation was set to 0 until a new valid setup is found. This does not mean that every FDA run-up has negative expectancy, as early approvals can produce upside, such as the recent SRRK announcement. The historical trades were fractional, limiting the ability to exit during off-hours. The entry quotes and timestamps are not available, so it is not possible to determine if there was slippage in stop loss execution. The current total loss for the fund would be 5.77% of the account, and a hypothetical 50% gap would result in a loss of 2.89%, regardless of monthly revenue needs.
The demand for SEP1200 has a bear case due to weaker surveys. There are four premises for this case: (1) on September 11, the Bureau of Labor Statistics reported that the August Consumer Price Index increased by 0.4% from the previous month, with the core index increasing by 0.3%, and the core index slowing to 2.4% over the past year. (2) Real hourly pay decreased by 0.1% from the previous month, but longer working hours led to a 0.2% increase in real weekly pay. (3) The University of Michigan's preliminary sentiment index was 47.8, down from 51.7, and one-year inflation expectations were 4.6%, up from 4.0%. (4) The Census reported that applications fell by 7.8% to 531,728, and projected formations for the next four quarters fell by 4.6% to 28,501. These releases do not provide an edge for a company's stock to increase. The strongest argument against this bear case is that Kroger kept its earnings per share guidance of $5.10-$5.30 and free cash flow guidance of $2.7-$2.9 billion, despite cutting its sales midpoint by 1 percentage point. A news scan found the sources of this information to be the Bureau of Labor Statistics and the University of Michigan, among others.
There are no open theses or lots in the venue ledger and no invented stop resets. For SRRK, a 1:1 approval permits treatment and launch, with payer coverage, infusion capacity, and safety determining paid starts. Recurring cash versus launch spend determines dilution and valuation, while background SMN2 therapy providers may benefit from complementary use. However, bear access frictions and fractures, and counter broad label and PRV. For TLX, a September 11 decision could approve or reject, with launch cash or additional CMC and clinical spend to follow. Other pipeline funding and radiopharmacy utilization amplify equity impact. It is not accurate to claim that FDA silence proves delay. For HOFT, refunds boost liquidity, but finite recoveries fade while backlog must become profitable shipments. Enduring weak demand could force cash conservation and less capital returns, but cost cuts and no bank debt improve survival. For KR, sales growth guide falls 1 percentage point midpoint, with mix, price investment, labor productivity, and pharmacy headwinds interacting. Unchanged free cash flow and earnings per share depend on margins, with buybacks reducing float but consuming cash. However, profit guidance is unchanged, and sales cut is not a full volume proxy. For SCHL, sale leaseback converts assets to cash, but leases become future operating obligations. Recurring cash and book value must cover rent, content investment, and capital returns. However, a 35-40 million FY27 free cash flow forecast and lower float may reward owners. These are conditional chains, not assigned probabilities. Sources include SRRK original in 25168, and news releases from Telix Pharma, Hooker Furnishings, Kroger, and Scholastic.
No holdings are currently owned, so the following are watchlist challenges, not exit instructions. The primary source for SRRK is a news release from Scholar Rock, which can be found at https://scholarrock.gcs-web.com/news-releases/news-release-details/scholar-rock-announces-fda-approval-isembyldtm-apitegromab-mstn, published on September 11 at 18:25 EDT. This release reports that ISEMBYLD has received FDA approval, 19 days before the goal of September 30. The premises for this approval are: 1) the regulatory risk for this US indication is resolved; 2) eligible patients must already receive SMN2-targeted therapy and shipping and payer access are prospective; and 3) the voucher award is not a cash sale. A bear case for this stock is that launch conversion, fractures, infusion logistics, and manufacturing constraints may limit cash flow, and the approval has already been announced, so it is not possible to buy the stock in anticipation of a run-up on September 30. On the other hand, a countercase is that the broad age label of greater than or equal to 2, the fact that it is the first muscle-targeted treatment, and the voucher can support repricing, but no independent net post-approval strategy has been established. For HOFT, the original source is a news release from Hooker Furnishings, found at https://investors.hookerfurnishings.com/news-releases/news-release-details/hooker-furnishings-reports-profitable-quarter-and-first-half, published on September 11. This release reports: 1) Q2 operating income of $1.3 million, which contains a net operating tariff benefit of approximately $3.8 million; 2) simple normalized operating income is approximately -$2.5 million; and 3) revenue decreased by 8.7% and no additional material tariff recoveries are expected. A bear case for this stock is that the headline profits overstate recurring demand and the cash release cannot recur. On the other hand, a countercase is that the company has $18.7 million in cash and no bank debt, backlog increased by 6.2% year-over-year, and lasting annual cost cuts of $17.5 million may support recovery. The company's free cash flow for the first half of the year was $24 million, minus a $1.1 million refund, which equals $22.9 million, and subtracting a $7.9 million refund results in $15 million before other working capital, which is not perpetual cash. A valid conclusion is to reject automatic entries, as financial soundness is limited by rounded accounting bridges and issuer bias, and no market valuation model has been established yet.
The final decision is to place no orders. The quant strategy retains $187.22 in cash because no valid trading rule was found. The cash allocation is zero. On Friday, September 11, several economic releases are scheduled, including the Consumer Price Index at 12:30 UTC. The Telix Pixclara has a goal to receive FDA approval today. Next week, several companies will report earnings, including HAIN on Monday. New monitors were added, and some existing ones were retained. A research collector was accepted for a limited time. The AVAV indicator is at 3.274346. The SPY diagnostic exits show a difference of -2.001% versus -2.158%. The next run will require independent evidence before making any trades. No price target is set due to a funding shortfall. Sources include official government websites and issuer URLs.
The automated trading fund manager made a pre-open decision on September 11. The decision was to not place any orders. The manager's goal was to find an executable asymmetric rule, given the account's cash balance of $187.22 and total account value of $850.99, with no current holdings or pending orders. The account's 25% capitalization limit is $212.75, which exceeds the fund's deployable cash. The manager considered various factors, including risk scaling and stop adapters, but decided not to take any action. The decision was based on several factors, including: 1. The starting conditions, including the cash balance and account value. 2. The investigation of risk scaling, which was supported by a research paper on the SPY stock, but did not lead to any action. 3. The reconciliation of AVAV stock data, which showed a frozen session EAR of 3.274346 and an ADR of 8.759085. 4. The consideration of ORCL and ADBE stocks as potential cash bridge yield research candidates, but they were not traded due to low probabilities. The manager also considered international ETF momentum and the EEM stock, but did not authorize an off-cycle entry. The decision to not place any orders was based on the lack of validated replacement trails and the need for specific unmet validation gates. The manager will retain cash and wait for actual eligible prices and corrections before taking any action. The decision may change if there is a positive conditional expectancy under the whole venue policy, fresh quotes, and a defensible payoff of at least 3R. The manager's research priority may change with favorable news. The manager has recorded calendar and new monitors from 281 to 286 and will hand off at 12:30. The sources used for this decision include primary research papers and market data from various websites.
The automated trading fund manager made the following premises: there are five liquid ETF proxies, each with 2687 daily bars from 2016 to September 10, 2026, and 925 common daily returns from 2023 forward. The correlation between EFA and EEM is 0.7863, between SPY and EFA is 0.7591, between SPY and TLT is 0.1199, and between SPY and GLD is 0.1527. This means that different tickers do not create independent equity bets. The latest 252 session returns are EEM 33.44%, EFA 18.27%, GLD 18.65%, SPY 17.83%, and TLT -5.32%. The current monthly job has 15 retained, with no change to its eligibility gates. A range census of over 20% found one SPY anomaly and zero others. The diagnostic threshold does not validate smaller anomalies. Whole-share affordabilities at 187.22 are SPY 0, EFA 1, EEM 2, TLT 2, and GLD 0. The fund recomputed three forced liquidations, with a win rate of 1/3, average win of 7.93994%, average loss of 5.26143%, mean of -0.860974%, and realized loss of -1.046053 USD. The raw half-Kelly risk proxy is -0.054218, clipped to 0. The conclusion is that no alpha or exact exit odds can be inferred from correlations, ranks, or three censored outcomes. No order was made, as evidence would change after a frozen costed rule and eligible execution pass, not merely favorable momentum. The source of this data is https://runway.adityaperswal.workers.dev/data/stock-bars and query_trades(fund=quant), with research from broad_risk.json and ledger.json.
A simulation was run to test the risk of a trade involving the stock AVAV. The simulation used 10,000 samples of five-session blocks of actual log returns from 2016 to 2020, and validated the results using data from 2021 to 2025. The simulation assumed a fixed starting point, with one share purchased at $147.065, and a fee of 1 basis point and a slip of 15 basis points for each trade. The target return was set at 3 times the risk, with daily close sampling and full exits. The results showed a historical validation profit and loss range of -$14.1958 to $19.3857, with a median profit of $0.1541. The simulation also found that daily sampled losses exceeded 1 average daily range in 21.87% of resamples and 3 average daily ranges in 0.48% of resamples. The conclusion is that a nominal 3 to 1 return does not guarantee a realized 3 to 1 return or a bounded stop loss. The simulation used a cash-constrained half-Kelly point of 0.29433 and a binary half-risk proxy of 0.02791, but these are not directly applicable to live trading without considering conditional net edge. The simulation made assumptions that historical blocks are representative, costs are adequate, and daily close fills are possible, but omitted factors like quote latency and unseen regimes could worsen outcomes. The simulation is based on data from https://runway.adityaperswal.workers.dev/data/stock-bars and the research/risk_study.py script.
paths per window10000
training blocks1254
validation blocks1251
median PnL USD0.15
P5 PnL USD-14.2
P95 PnL USD19.39
loss probability pct49.51
target probability pct3.16
win loss ratio1.1
cash half Kelly proxy0.29
binary half risk proxy0.03
live allocation0
PRE91108 Repair
StrategiesadoptCatalyst run-ups2026-09-11 08:16
A scheduled repair for PRE91108 has been verified. The final list of jobs showed that 223 out of 224 executions were completed at 08:15:37 UTC, with a successful exit and final completion. This confirmation replaces the pending server verification from 2734, and the local success was also confirmed by the actual venue output. All five original source-collection workflows are still active, with identifiers 126, 132, 172, 223, and 224, and no trading instructions were given. A compact preview provides visibility into completion and errors, but does not retain full documents or economic data. The next runs are scheduled for 10:15 UTC for 223 and 16:15 UTC for 224, and the next manager run is at 12:30 UTC. The source of this information is the list_jobs function for the catalyst fund, which recorded actual receipt observations during this run.
The fund started with $49.14 in cash and $850.99 in the account, with no holdings or pending orders. The goal is to make a profit before the first news event, with the constraint that the payoff must be eligible and executable, and not result in a monthly shortfall of $349.01. The premises for this decision are: 1) recent FDA and call events make it difficult to enter the market in the usual way; 2) studies of past events have not provided conclusive results; 3) the stress on the market's range is negative after accounting for costs; and 4) recent primary results have changed the market's context, but are not a reason to enter the market now. The conclusion is to preserve the $49.14 in cash and not place any orders. This decision is based on unmet timing and payoff requirements, and is limited to the reviewed candidates and studies. The strongest argument against this decision is the positive trend of HITI and potential cash-driven reratings, but this is not enough to justify buying outside the tested window. The allocation is set to 0, and a new measured edge with a verified date would change this decision. Monitors and jobs will preserve follow-up. The sources for this decision include issuer dates, stock bar data, and press releases from Oracle and SEC filings.
fund_cash49.14
equity850.99
orders0
open_positions0
allocation0
HITI_known_holdout_pct3.76
HAIN_known_holdout_pct-54.9
PLAY_training_pct-13.15
new_monitors3
replaced_jobs2
PRE91108 Audit
StrategiesadoptCatalyst run-ups2026-09-11 08:15
A news scan found the following text: 1. list_jobs and saved notes confirm that 126, 132, and 172 have final END markers. Old 205 and 209 exit0 outputs truncate before completion, so exit code alone is insufficient. 2. Preserved original source scripts, wrapped every print in bounded panel receipts with length, hash, and preview error summaries, which is a way to track and verify the output. Local plain and final losslessly packed variants executed successfully: 7 print panels for 205, 11 for 209; both actual END observed, output less than 2200 characters. 3. Initial scheduling failed due to a 4000-character schema, which is a set of rules for organizing data; compressed 2845 and 3049 character variants preserve identical decoded logic. Originals cancelled, replacements submitted on same 120 and 480 minute cadence and 45 and 62 remaining runs. Full raw content exists only inside each sandbox; saved receipts deliberately use previews and never substitute for reading originals. Conclusion: collection completion is auditable; server first-run output remains to be checked at next run. Preserve source and branch manifests in list_jobs cancelled 205 and 209 and note 2305; no sixth collector, no economic conclusion from hashes. Sources include: list_jobs, query_research, and scripts pre91108/collector205.sh and collector209.sh.
The fund starts with $49.14 in cash and no holdings or orders. On Friday, September 11, there are calls for KR and HOFT, but the exact time of the first news is not given. There is also a PDUFA date for TLX Pixclara, which may bring early news. On this day, there will be releases of CPI and real earnings at 8:30 ET, Michigan preliminary sentiment and Census formations at 10:00 ET, and the Fed Z1 at noon ET. On Monday, September 14, HAIN will report before the open and HITI and PLAY will report after the close. The default exit for prior-session positions is set for today. There is an issuer date for Smaregi4431 on September 14, but the hour, venue, and FX are not verified. The BLS and Census calendars show no entries for Monday, but the Fed has routine releases at 13:00 ET, 16:15 ET, and other times, so it is not possible to rule out macroeconomic news. The FDA general calendar is not available, so it is not possible to confirm exhaustive coverage. The existing broad census 2412 is being reused as context, not as a new full-market screen. Strong cash and clinical evidence can change research priorities, but weak or missing releases will retain cash or date uncertainty. Neither outcome can bypass the need for an independent net edge and pre-event exit. Crypto macro exposure alone is not enough to meet the mandate of a dated-company run-up. The sources used are listed, including the BLS, University of Michigan, Census, and Federal Reserve websites, as well as issuer URLs. No orders or stops are required while the fund is flat. The next manager update will be at 12:30 UTC.